RxDoctor Payments Data

Bonnie Lohrbach, MD

Family Medicine · Tampa, FLNPI 1114995370

Payments from drug & device makers

$719in general payments, 2019–2025

Across 42 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$104
  • Boehringer Ingelheim$99
  • Kowa Pharmaceuticals America, Inc.$80
  • AstraZeneca$55
  • Daiichi Sankyo Inc.$54
  • Sanofi-aventis U.S. LLC$43
  • plus $284 from 15 others

What the payments were for

  • Food & beverage$719100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$719 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$55,889
Medicare patients
125
Services billed
904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin101$127,010
TrulicityDulaglutide91$98,830
OzempicSemaglutide80$86,458
JanuviaSitagliptin Phosphate53$68,928
FarxigaDapagliflozin Propanediol38$61,737
LinzessLinaclotide48$53,210
Tresiba Flextouch U-200Insulin Degludec32$33,388
MounjaroTirzepatide31$31,583
EliquisApixaban29$29,716
Tresiba Flextouch U-100Insulin Degludec49$26,032
VascepaIcosapent Ethyl23$9,054
SymbicortBudesonide/Formoterol Fumarate32$8,771
Breo ElliptaFluticasone/Vilanterol16$6,399
Lantus SolostarInsulin Glargine,hum.Rec.Anlog56$5,606
Humalog Kwikpen U-100Insulin Lispro31$5,331

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$104$130,413122 claims
Boehringer IngelheimJardiance$99$127,010101 claims
Novo NordiskOzempic, Novolog$14$87,52295 claims
AstraZenecaFarxiga, Symbicort$55$70,50970 claims
AbbVieLinzess$16$53,21048 claims
PfizerEliquis$21$29,71629 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →